Immunosuppression after liver transplantation

Journal of Hepatology

Volumn 24, Issue 4, 1996, Pages 503-505

  Lucey, Michael R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; TACROLIMUS;

ARTICLE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0029930471     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(96)80173-5     Document Type: Article

References (15)

1. Iwatsuki S, Starzl TE, Todd S, Gordon RD, Esquivel CO, Tzakis A, Makowka L, Marsh JW, Koneru B, Stieber A, Klintmalm G, Husberg B. Experience in 1000 liver transplants under cyclosporin-steroid therapy: a survival report. Transplant Proc 1988; 20: 498-504.
2. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporin for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110-5.
3. European FK506 Multicenter Liver Study Group. A randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994; 344: 423-8.
4. Gray DWR. Mycophenolate mofetil for transplantation: new drug, oldfs problems? Lancet 1995; 346: 39.
5. Starzl TE, Kaupp HA, Brock DR, Linman JW. Studies on the rejection of the transplanted homologous dog liver. Surg Gynecol Obstet 1961; 116: 135-40.
6. Starzl TE, Marchioro TL, Porter KA, Taylor PD, Faris TD, Herrmann TJ, Hlad CJ, Waddell ER. Factors determining short- and-long-term survival after orthotopic liver transplantation in the dog. Surgery 1965; 58: 131-55.
7. Fischer LR, Henley KS, Lucey MR. Acute cellular rejection after liver transplantation: variability, morbidity and mortality. Liver Transplant Surg 1995; 1: 11-5.
8. Padbury RTA, Gunson BK, Dousset B, Hubscher SG, Buckels JAC, Neuberger JM, Elias E, McMaster P. Steroid withdrawal from long-term immunosuppression in liver allograft recipients. Transplantation 1993; 55: 789-94.
9. MacDiarmid SV, Farmer DA, Goldstein L, Martin P, Vargas J, Busuttil RW. A prospective randomized trial of steroid withdrawal in orthotopic liver transplant recipients. Presented to the ASTP 14th Annual Meeting, Chicago, 1995.
10. Wiesner RH. Optimal dosing of cyclosporin in liver transplantation. Presented to the ASTP 14th Annual Meeting, Chicago, 1995.
11. Burke JF, Pirsch JD, Ramos EL, Salomon DR, Stablein DM, Van Buren DH, West JC. Long-term efficacy and safety of cyclosporin in renal-transplant recipients. N Engl J Med 1994; 331: 358-68.
12. Rasmussen A, Davies H, FF S, Jameson NV, Evans DB, Calne RY. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 1995; 59: 919-21.
13. Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, Ramos H, Todo S, Tzakis A, Fung JJ, Nalesnik M, Zeevi A, Rudert WA, Kocova M. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127-52.
14. Devlin J, Slapak G, Portmann B, Williams R. Immunosuppression withdrawal in long-term liver recipients. Hepatology 1994; 20: 124A.
15. Mor E, Gonwa TA, Husberg Bo S, Goldstein RM, Klintmalm G. Late-onset acute rejection in orthotopic liver transplantation-associated risk factors and outcome. Transplantation 1992; 54: 821-4.